Clinical Trial: An Open Label, Single Treatment, Single Arm, Multiple Dose Phase-2 Study to Evaluate the Pharmacokinetics, Safety, and Clinical Performance of EscharEx (EX-03) in Participants With Venous Leg Ulcers

U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07692178) titled 'An Open Label, Single Treatment, Single Arm, Multiple Dose Phase-2 Study to Evaluate the Pharmacokinetics, Safety, and Clinical Performance of EscharEx (EX-03) in Participants With Venous Leg Ulcers' on May 04.

Brief Summary: This is a pharmacokinetics (PK) study - the main objective of this study is to assess the PK, safety and clinical performance of 5% EscharEx (EX-03 formulation) in debridement of Venous Leg Ulcers

Study Start Date: Aug., 2026

Study Type: INTERVENTIONAL

Condition: Venous Leg Ulcer (VLU)

Intervention: DRUG: EX-03

a sterile lyophilized powder containing a concentrate of proteolytic enzymes enriched in brome...